Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I wanted to

" I think the only reason the Commission decided to review was the NDoC jury verdict."

I agree, if not by chance that the NDOC case became final, within weeks of the ITC case; this case would never have seen a review. Talk about a coincidence that was in our favor! How many other companies have presented to the ITC, been denied and then let there case drop?

Share
New Message
Please login to post a reply